C07C 311/18
To an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen
Official title: to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
C07C311/18 (To an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen) appears on 216 US grants and 169 published applications in this corpus.
Search patents in C07C- Granted patents
- 216
- Published applications
- 169
- Assignees
- 123
- Inventors
- 701
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 5 | 0 |
| 1993 | 5 | 0 |
| 1994 | 6 | 0 |
| 1995 | 3 | 0 |
| 1996 | 16 | 0 |
| 1997 | 21 | 0 |
| 1998 | 12 | 0 |
| 1999 | 7 | 0 |
| 2000 | 8 | 0 |
| 2001 | 10 | 1 |
| 2002 | 15 | 9 |
| 2003 | 11 | 11 |
| 2004 | 4 | 10 |
| 2005 | 5 | 12 |
| 2006 | 6 | 12 |
| 2007 | 6 | 15 |
| 2008 | 2 | 10 |
| 2009 | 4 | 8 |
| 2010 | 10 | 12 |
| 2011 | 6 | 5 |
| 2012 | 6 | 5 |
| 2013 | 2 | 8 |
| 2014 | 6 | 9 |
| 2015 | 8 | 3 |
| 2016 | 4 | 7 |
| 2017 | 6 | 5 |
| 2018 | 4 | 8 |
| 2019 | 4 | 3 |
| 2020 | 3 | 3 |
| 2021 | 5 | 3 |
| 2022 | 0 | 6 |
| 2023 | 0 | 2 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Calpain-2 inhibitor compounds and methods of treatment21 Apr 2026US 12,606,520 B2Western University of Health Sciences
- Sulfur and amide tropolone inhibitors of nucleotidyl transferases and uses therefor21 Apr 2026US 12,606,529 B2Research Foundation of the City University of New York
- Method for synthesis of diazabicyclo[6.2.0]decane related compounds23 Sep 2025US 12,421,246 B2Eisai R&D Management Co., Ltd.
- Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith25 Jun 2024US 12,017,975 B2The University of British Columbia
- Cannabinoid receptor CB2 ligand 4-(aminomethyl)-N, N-dialkylanilines13 Jul 2021US 11,059,778 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Method for synthesis of diazabicyclo[6.2.0]decane related compounds14 May 2026US 2026/0132144 A1Eisai R&D Management Co., Ltd.
- Modulators of protein phosphatase 2a (pp2a) and methods using same30 May 2024US 2024/0174603 A1Rappta Therapeutics Oy
- Myc-max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith4 May 2023US 2023/0134821 A1The University of British Columbia
- Calpain-2 inhibitor compounds and methods of treatment23 Mar 2023US 2023/0091121 A1Western University of Health Sciences
- Sulfur and amide tropolone inhibitors of nucleotidyl transferases and uses therefor3 Nov 2022US 2022/0348546 A1Research Foundation of the City University of New York
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Sulfonamide inhibitors of aspartyl protease147US 5,585,397 AVertex Pharmaceuticals Incorporated · 1996
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Retroviral protease inhibiting compounds94US 5,541,206 AAbbott Laboratories · 1996
- Substituted aminomethyltetralins and their heterocyclic analogues81US 5,137,901 ABayer Aktiengesellschaft · 1992